Cenduit, LLC To Highlight Advanced IRT Solutions At DIA China
WHAT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at the DIA China 8th Annual Meeting from May 15-18 in Beijing, China.
“The DIA China Annual Meeting is the perfect international network to discuss vital trial and supply challenges and proactive solutions,” said Ian Hutchings, project manager at Cenduit. “We look forward to discussing our innovative IRT systems with attendees, as well as discussing how our company can deliver custom solutions for costs, drug enhancements and patient management in clinical trials.”
Attendees are invited to stop by the Cenduit booth, #C07, to learn how the company’s IRT solutions can help sponsors increase efficiencies and reduce costs to get their product to market faster.
WHO: Cenduit attendees include:
• Sharad Gupta, ?senior vice president operations, Cenduit
• Stacy Gletzakos, global head business development, marketing & account management, Cenduit
• Ian Hutchings, project manager, Cenduit
• Joe Zhou, business development manager, Cenduit
WHEN: May 15, 2016, 8:30 a.m. to May 18, 2016, 5:30 p.m.
WHERE: China National Convention Center
Beijing Chaoyang
100062 Beijing, China
DETAILS: For media inquiries, please contact Jen Caro at Largemouth Communications, (919) 459-6456 jennifer@largemouthpr.com.
ABOUT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.
“The DIA China Annual Meeting is the perfect international network to discuss vital trial and supply challenges and proactive solutions,” said Ian Hutchings, project manager at Cenduit. “We look forward to discussing our innovative IRT systems with attendees, as well as discussing how our company can deliver custom solutions for costs, drug enhancements and patient management in clinical trials.”
Attendees are invited to stop by the Cenduit booth, #C07, to learn how the company’s IRT solutions can help sponsors increase efficiencies and reduce costs to get their product to market faster.
WHO: Cenduit attendees include:
• Sharad Gupta, ?senior vice president operations, Cenduit
• Stacy Gletzakos, global head business development, marketing & account management, Cenduit
• Ian Hutchings, project manager, Cenduit
• Joe Zhou, business development manager, Cenduit
WHEN: May 15, 2016, 8:30 a.m. to May 18, 2016, 5:30 p.m.
WHERE: China National Convention Center
Beijing Chaoyang
100062 Beijing, China
DETAILS: For media inquiries, please contact Jen Caro at Largemouth Communications, (919) 459-6456 jennifer@largemouthpr.com.
ABOUT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.